Filing Details
- Accession Number:
- 0000899243-18-024819
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-19 21:22:25
- Reporting Period:
- 2018-05-15
- Accepted Time:
- 2018-09-19 21:22:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643756 | G. John Aunins | C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-15 | 14,279 | $8.08 | 146,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-15 | 14,279 | $7.57 | 132,369 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-09-17 | 14,279 | $7.27 | 118,090 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2018.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $7.8800 to $8.1400. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This filing is being reported late due to an inadvertent administrative error.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $7.2500 to $7.7600. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This filing is being reported late due to an inadvertent administrative error.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $7.0914 to $7.5600. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
